Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7719542

Concept 2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-09-30
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
Key financial data of group
Business results of group
Revenue
318,011,000,000 JPY
647,096,000,000 JPY
1,300,316,000,000 JPY
317,183,000,000 JPY
639,754,000,000 JPY
Profit (loss) before tax
128,298,000,000 JPY
218,113,000,000 JPY
101,224,000,000 JPY
Profit (loss), attributable to owners of parent
49,307,000,000 JPY
103,867,000,000 JPY
164,679,000,000 JPY
39,649,000,000 JPY
82,117,000,000 JPY
Comprehensive income, attributable to owners of parent
150,222,000,000 JPY
198,539,000,000 JPY
164,168,000,000 JPY
Equity attributable to owners of parent
1,282,685,000,000 JPY
1,268,289,000,000 JPY
1,350,907,000,000 JPY
Total assets
1,886,926,000,000 JPY
1,858,205,000,000 JPY
1,895,713,000,000 JPY
Basic earnings (loss) per share
25.50
53.20
81.11
19.39
39.97
Diluted earnings (loss) per share
53.14
81.02
39.92
Ratio of owners' equity to gross assets
0.680 xbrli:pure
0.683 xbrli:pure
0.713 xbrli:pure
Cash flows from (used in) operating activities
112,086,000,000 JPY
312,614,000,000 JPY
115,258,000,000 JPY
Cash flows from (used in) investing activities
-7,773,000,000 JPY
-121,799,000,000 JPY
-72,666,000,000 JPY
Cash flows from (used in) financing activities
-136,474,000,000 JPY
-203,429,000,000 JPY
-85,873,000,000 JPY
Cash and cash equivalents
306,867,000,000 JPY
331,731,000,000 JPY
307,923,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.